DK453687D0 - CEPHALOSPORIN DERIVATIVES USED AS INTERMEDIATES IN THE PREPARATION OF ANTIBACTERYLY EFFECTIVE 3-CEPHEM-4-CARBOXYLIC ACID DERIVATIVES - Google Patents

CEPHALOSPORIN DERIVATIVES USED AS INTERMEDIATES IN THE PREPARATION OF ANTIBACTERYLY EFFECTIVE 3-CEPHEM-4-CARBOXYLIC ACID DERIVATIVES

Info

Publication number
DK453687D0
DK453687D0 DK453687A DK453687A DK453687D0 DK 453687 D0 DK453687 D0 DK 453687D0 DK 453687 A DK453687 A DK 453687A DK 453687 A DK453687 A DK 453687A DK 453687 D0 DK453687 D0 DK 453687D0
Authority
DK
Denmark
Prior art keywords
antibacteryly
cephem
intermediates
preparation
effective
Prior art date
Application number
DK453687A
Other languages
Danish (da)
Other versions
DK155329C (en
DK155329B (en
DK453687A (en
Inventor
Marc Montavon
Roland Reiner
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK453687A publication Critical patent/DK453687A/en
Publication of DK453687D0 publication Critical patent/DK453687D0/en
Publication of DK155329B publication Critical patent/DK155329B/en
Application granted granted Critical
Publication of DK155329C publication Critical patent/DK155329C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK453687A 1974-06-21 1987-08-28 7-AMINOCEPHALOSPORINES USED AS INTERMEDIATES IN THE PREPARATION OF THERAPEUTIC EFFECTIVE 7-ACYLAMINO-CEPHALOSPORINES DK155329C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH853774A CH609989A5 (en) 1974-06-21 1974-06-21 Process for the preparation of acyl derivatives
CH853774 1974-06-21

Publications (4)

Publication Number Publication Date
DK453687A DK453687A (en) 1987-08-28
DK453687D0 true DK453687D0 (en) 1987-08-28
DK155329B DK155329B (en) 1989-03-28
DK155329C DK155329C (en) 1989-08-07

Family

ID=4341690

Family Applications (2)

Application Number Title Priority Date Filing Date
DK271975A DK153155C (en) 1974-06-21 1975-06-17 ANALOGY PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINES
DK453687A DK155329C (en) 1974-06-21 1987-08-28 7-AMINOCEPHALOSPORINES USED AS INTERMEDIATES IN THE PREPARATION OF THERAPEUTIC EFFECTIVE 7-ACYLAMINO-CEPHALOSPORINES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK271975A DK153155C (en) 1974-06-21 1975-06-17 ANALOGY PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINES

Country Status (25)

Country Link
JP (1) JPS625917B2 (en)
AT (1) AT337897B (en)
AU (1) AU498387B2 (en)
BE (1) BE830455A (en)
BR (1) BR7503782A (en)
CA (1) CA1111021A (en)
CH (1) CH609989A5 (en)
CU (1) CU34293A (en)
DD (1) DD121113A5 (en)
DE (1) DE2527291A1 (en)
DK (2) DK153155C (en)
FI (1) FI751815A (en)
FR (1) FR2275215A1 (en)
GB (1) GB1471804A (en)
HU (1) HU170576B (en)
IE (1) IE41888B1 (en)
IL (1) IL47299A (en)
LU (1) LU72771A1 (en)
NL (1) NL180665C (en)
NO (1) NO752202L (en)
NZ (1) NZ177508A (en)
PH (1) PH13030A (en)
SE (1) SE431755B (en)
SU (2) SU635873A3 (en)
ZA (1) ZA753086B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7805715A (en) * 1977-06-03 1978-12-05 Hoffmann La Roche METHOD FOR PREPARING ACYL DERIVATIVES.
JPS5419990A (en) * 1977-07-14 1979-02-15 Shionogi & Co Ltd Dihydrotriazinylthioxacephalosporin
MC1259A1 (en) * 1978-05-30 1980-01-14 Hoffmann La Roche ACYL DERIVATIVES
FR2474030A1 (en) * 1980-01-17 1981-07-24 Rhone Poulenc Ind 2-Mercapto-1,2,4-triazine, 1,3,4-triazole or tetrazole derivs. - useful as intermediates for antibacterial cephalosporin(s)
FR2494278A1 (en) * 1980-11-20 1982-05-21 Rhone Poulenc Ind NEW DERIVATIVES OF CEPHALOSPORIN, THEIR PREPARATIONS AND THE MEDICINAL PRODUCTS CONTAINING THEM
JP2004538265A (en) * 2001-04-19 2004-12-24 ビオフェルマ ムルシア，エス．アー． Method for producing 3-cephalosporanic acid derivative using α-keto acid derivative
EP2250156B1 (en) 2008-03-05 2015-05-06 Merck Patent GmbH Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868369A (en) * 1972-11-14 1975-02-25 Smithkline Corp 3-heterocyclicthiomethylcephalosporins

Also Published As

Publication number Publication date
SE431755B (en) 1984-02-27
PH13030A (en) 1979-11-15
SE7506908L (en) 1975-12-22
DK153155B (en) 1988-06-20
ZA753086B (en) 1976-04-28
AU8191275A (en) 1976-12-09
JPS5113793A (en) 1976-02-03
IL47299A (en) 1979-01-31
JPS625917B2 (en) 1987-02-07
DE2527291C2 (en) 1988-01-14
LU72771A1 (en) 1977-03-04
NL180665B (en) 1986-11-03
NZ177508A (en) 1978-04-03
DK155329C (en) 1989-08-07
DK155329B (en) 1989-03-28
IE41888L (en) 1975-12-21
IL47299A0 (en) 1976-10-31
CA1111021A (en) 1981-10-20
FR2275215B1 (en) 1980-05-16
GB1471804A (en) 1977-04-27
AU498387B2 (en) 1979-03-08
FR2275215A1 (en) 1976-01-16
BR7503782A (en) 1976-07-06
SU635873A3 (en) 1978-11-30
CU34293A (en) 1979-01-16
NL180665C (en) 1987-04-01
DK453687A (en) 1987-08-28
NO752202L (en) 1975-12-23
NL7507390A (en) 1975-12-23
FI751815A (en) 1975-12-22
SU589921A3 (en) 1978-01-25
ATA476975A (en) 1976-11-15
AT337897B (en) 1977-07-25
IE41888B1 (en) 1980-04-23
CH609989A5 (en) 1979-03-30
DE2527291A1 (en) 1976-01-08
DD121113A5 (en) 1976-07-12
DK271975A (en) 1975-12-22
DK153155C (en) 1988-10-31
HU170576B (en) 1977-07-28
BE830455A (en) 1975-12-22

Similar Documents

Publication Publication Date Title
DK155086C (en) ALFA-PROTECTED OXYIMINO-BETA-OXO-GAMMA-HALOGENIC ACID DERIVATIVES FOR USING INTERMEDIATES IN THE PRODUCTION OF CEPHEM COMPOUNDS
DK207175A (en) PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINS WITH ALFA-ACYLAMINE acetic acid side chain
DK289175A (en) PROCEDURE FOR THE PREPARATION OF CYCLOHEXYLESTS OF VINCAMIC ACID DERIVATIVES
DK348678A (en) 3-HYDROXYCROTONIC ACID DERIVATIVES FOR USE AS INTERMEDIATE PREPARATIONS IN THE PREPARATION OF ANTIOBIOTIC ACTIVITIES 3-CEPHEM COMPOUNDS
DK157080C (en) 7BETA-AMINO-3-CEPHEM-3-AMINO-4-CARBOXYLIC ACID DERIVATIVES FOR USING INTERMEDIATES IN THE PREPARATION OF 7BETA-AMINO-3-CEPHEM-3-OL-4-CARBOXYLIC ACID COMPOUNDS
DK148796C (en) CEPHALOSPORANIC ACID DERIVATIVES USED AS INTERMEDIATES IN THE MANUFACTURE OF OTHER CEPHALOSPORANIC ACID DERIVATIVES
DK591975A (en) PROCEDURE FOR THE PREPARATION OF PHENYLACIC ACID DERIVATIVES
DK161201C (en) CEPHALOSPORIN DERIVATIVES FOR USE AS INTERMEDIATE FOR THE PRODUCTION OF CEPHALOSPORIN DERIVATIVES
DK453687D0 (en) CEPHALOSPORIN DERIVATIVES USED AS INTERMEDIATES IN THE PREPARATION OF ANTIBACTERYLY EFFECTIVE 3-CEPHEM-4-CARBOXYLIC ACID DERIVATIVES
DK446978A (en) PROCEDURE FOR THE PREPARATION OF CEPHALOSPORANIC ACID DERIVATIVES
DK499075A (en) PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINS
DK364775A (en) PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINS
DK446575A (en) PROCEDURE FOR THE PREPARATION OF CEPHALOSPORANIC ACID DERIVATIVES
DK153554C (en) PROCEDURE FOR THE PREPARATION OF 7-AMINOCEPHALOSPORANIC ACID DERIVATIVES
DK220375A (en) PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINS
DK555680A (en) BENZOCYCLOPTATHIOPHENDER DERIVATIVES USED AS INTERMEDIATES IN THE PREPARATION OF THERAPEUTICALLY EFFECTIVE BENZOCYCLOPTATHIOPHENDER DERIVATIVES
DK155218C (en) THIAZOLYLIC ACETIC ACID COMPOUNDS USED AS INTERMEDIATES IN THE PRODUCTION OF CEPHEM COMPOUNDS
DK158787C (en) 3-PYRROLO-5-SULFAMOYLBENZOIC ACID DERIVATIVES USED AS INTERMEDIATES IN THE PREPARATION OF THE SIMILAR PYRROLOD COMPOUNDS
DK473875A (en) PROCEDURE FOR THE PREPARATION OF CLAVULANIC ACID DERIVATIVES
DK143941C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF CEPHALOSPORANIC ACID DERIVATIVES
DK72976A (en) PROCEDURE FOR THE PREPARATION OF 7-AMINOCEPHALOSPORANIC ACID DERIVATIVES
DK145000C (en) CEPHALOSPORANIC ACID DERIVATIVES USED AS INTERMEDIATE IN THE MANUFACTURE OF OTHER CEPHALOSPORANIC ACID DERIVATIVES
DK145599C (en) INTERMEDIATE FOR USE IN THE PREPARATION OF CEPHALOSPORANIC ACID DERIVATIVES
DK155660C (en) 1-ARYLOXY-4-CHLOR-2-BUTANOLS USED AS INTERMEDIATES IN THE PREPARATION OF 1-ARYLOXY-4-AMINO-2-BUTANOLS
DK401275A (en) PROCEDURE FOR THE PREPARATION OF ACYL DERIVATIVES OF 7-AMINO-3-DESACETOXYCEPHALOSPORANIC ACID

Legal Events

Date Code Title Description
PUP Patent expired